Srinivasa R. Sanikommu

Srinivasa R. Sanikommu

Hematology | Oncology

1021 Morehead Medical Drive
Building 2, Suite 60201
Charlotte, NC 28204

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Switching patients with PNH from pegcetacoplan to iptacopan: a case series.

Switching patients with PNH from pegcetacoplan to iptacopan: a case series.

Journal: Hematology (Amsterdam, Netherlands)

Published: February 09, 2026

Distress and Care Utilization in Patients with Myeloproliferative Neoplasms.

Distress and Care Utilization in Patients with Myeloproliferative Neoplasms.

Journal: Acta haematologica

Published: October 09, 2024

Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.

Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.

Journal: Transplantation and cellular therapy

Published: July 15, 2024

Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice.

Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice.

Journal: Annals of hematology

Published: January 15, 2024

Outcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclax.

Outcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclax.

Journal: Leukemia research

Published: June 17, 2022

Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic Malignancy.

Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic Malignancy.

Journal: JCO oncology practice

Published: June 16, 2022

Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia.

Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia.

Journal: Blood

Published: April 13, 2022

Optimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF).

Optimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF).

Journal: Leukemia & lymphoma

Published: February 02, 2022

Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantation.

Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantation.

Journal: Journal of clinical apheresis

Published: July 09, 2020

Genomics of therapy-related myeloid neoplasms.

Genomics of therapy-related myeloid neoplasms.

Journal: Haematologica

Published: August 16, 2019

Curative potential of chemoimmunotherapy in diffuse large B cell lymphoma with hepatic and/or renal dysfunction.

Curative potential of chemoimmunotherapy in diffuse large B cell lymphoma with hepatic and/or renal dysfunction.

Journal: British journal of haematology

Published: March 30, 2019

Higher Incidence of Hemorrhagic Cystitis Following Haploidentical Related Donor Transplantation Compared with Matched Related Donor Transplantation.

Higher Incidence of Hemorrhagic Cystitis Following Haploidentical Related Donor Transplantation Compared with Matched Related Donor Transplantation.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: October 25, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026